This paper describes a prospective, observational, single-centre study of 20 consecutive patients with clinical stage I lung carcinoma undergoing anatomical sublobar resections using complete video-assisted thoracoscopic surgery (cVATS). Thirteen male and seven female patients with a median age of 68 (range 57-84) years and a median of four (range 0-9) relevant comorbid conditions presented with five right-sided and 15 left-sided tumours, with a median diameter of 2.3 (range 1.0-5.2) cm. Thirteen segmentectomies, three bisegmentectomies and four trisegmentectomies with lymphadenectomy of the N1 stations and the mediastinum were performed, with a median duration of 212 (range 91-397) min, a conversion rate to open surgery of 20% and conversion to lobectomy of 10%. In five patients, we noted 10 postoperative adverse events but no transfusions, no readmissions and zero mortality. Median drainage time was six days, with a median hospital stay of 8.5 days. According to the pTNM classification, 10, three, one, and six patients were staged as Ia, Ib, IIb and IIIa, respectively. The distance between the tumour and the parenchymal stapling line exceeded the tumour diameter in 56%, 0% and 0% of T1a, T1b and T2 tumours, respectively. To conclude, cVATS anatomical sublobar resections are technically feasible. We observed a favourable postoperative course in 20 multimorbid or aged patients. In patients fit for lobectomy, the tumour diameter should not exceed 2 cm.
Introduction
Anatomical segmental lung resection is defined as the excision of one or more bronchopulmonary segments of a lobe, with individual ligation and division of the corresponding bronchovascular structures. The first description of segmentectomy by Churchill and Belsey [1] in 1939 contained the favourable prognosis that 'the bronchopulmonary segment may replace the lobe as the surgical unit of the lung'. The first widely accepted indication for segmentectomy was, and still is, inflammatory disease, whereas in oncological surgery lobectomy remained the standard resection. This strategy probably implies an overtreatment of small peripheral tumours [2] , and excludes functionally compromised patients from resection. Furthermore, it is the functionally compromised, the multimorbid and the elderly patient who benefits most not only from parenchy ma-sparing sublobar resections, but, in analogy to lobectomy [3] , also from a thoracoscopic approach.
Against a background of demographic changes and advanced computed tomography (CT) scanners detecting a plethora of small and sometimes malignant nodules, thoracoscopic segmentectomy appears to be a feasible surgical solution to two substantial and increasing clinical challenges. As reported experience with thoracoscopic segmentectomy is limited [4, 5] , we decided to provide a preliminary report on our first 20 highly selected oncological patients who underwent complete video-assisted thoracoscopic surgery (cVATS) [6] segmentectomy.
Methods
This institutional report describes demographic, clinical, oncological, pathological, technical, and feasibility data for 20 consecutive anatomical sublobar resections for clinical stage I lung carcinoma collected prospectively in a VATS lobectomy database [7] . Inclusion criteria were proven or suspected clinical stage I lung carcinoma confined to one segment or segmental group, at least one strong argument against a lobectomy, most often a high-risk scenario with poor pulmonary function and relevant comorbiditiy, and an oncological dilemma in patients with 
Results
From 2006 to 2009, 13 male and seven female patients underwent cVATS segmentectomies, representing 26% of all institutional thoracoscopic anatomical resections for earlystage lung carcinoma (Fig. 1) . The median age was 68 (range 57-84) years, with 35% hepto-and octogenarians. At admission, we noted a median of four (range 0-9) relevant comorbidities, with a median regular medication of four (range 0-13) different drugs. The incidence of pulmonary, cardiovascular, oncological and other diseases was 9/20, 13/20, 9/20 and 10/20, respectively. None of the patients was receiving neoadjuvant treatment.
Sublobar resection was performed for poor lung function in nine patients, to get a timely and definitive surgical solution for centrally located, histologically unconfirmed tumours unsuitable for diagnostic wedge resection in 10 patients, and to offer curative treatment for bilateral synchronous tumours in one patient, combining the sublobar resection with definitive chemoradiation therapy of a contralateral central tumour with a different histology. Invasive mediastinal staging was done by VAMLA, endobronchial ultrasound-guided transbronchial needle aspiration and endoscopic ultrasound fineneedle aspiration in eight, three and two patients, respectively. The targets of cVATS sublobar resection were five rightsided tumours (three S2, two S6) and 15 left-sided tumours (three S1-3, three S2, three S4/5, five S6, and one S8-10), with a median diameter of 2.3 (range 1.0-5.2) cm (Fig. 2) .
Eight different types of sublobar resection were performed (Table 1) . Their median duration was 212 (range 91-397) min. The dissection proceeded from posterior to anterior for the dorsally located segments S2 and S6 ( Fig.  3a-c) , and in an anterior-posterior direction for all other segments ( Fig. 3d-f ). As the anatomical structures were divided in the order suggested by the anatomy, typical patterns were identified ( Table 1 ). The yield of systematic lymph node dissection was a median of 4.5 (range 1-8) lymph node stations, details of which are given in Table 2. controlled extrapulmonary primary and one unconfirmed tumour located centrally within one segment and thus unsuitable for wedge resection. The preoperative location of the tumour within a segment or a group of segments and its relation to the segmental bronchus and vessels was established by CT-scan with coronary reconstructions. Informed written consent was obtained from all patients. The procedures were designed as a small-scale adaptation of VATS lobectomy and performed by two surgeons in a complete videothoracoscopic technique [6] via an anterior auxiliary thoracotomy measuring 2-4 cm without rib spreading, and two 10 mm epiphrenic trocars [8] . Thus, the procedure was guided by the videocamera without direct vision, and performed with thoracoscopic instruments, in contrast to assisted VATS procedures [6] in which a longer utility incision allows direct inspection of the operation field, and the application of opensurgery instruments. Commercially available thoracoscopic cameras, instruments and staplers (Storz, Tuttlingen, Germany; Duffner, Tuttlingen, Germany; Johnson & Johnson, Norderstedt, Germany; Ethicon; Covidien Autosuture, Neustadt, Germany and LigaSure) were used. The segmental vessels, bronchus, fissure and intersegmen tal parenchyma were dissected and stapled separately; small vessels were clipped, sealed by electrothermal coagulation and ligated. Before firing the bronchial stapler, differential ventilation was applied to make sure the correct bronchus was to be divided, and to define where to place the intersegmental parenchymal stapling line. As far as we can provide surgical strategies for certain segments or groups, these are compiled in Table 1 .
Systematic lymph node dissection was carried out in accordance with our institutional practice for VATS or open lobectomy, yielding the peribronchial, interlobar, hilar and ipsilateral mediastinal nodes, and combined with videoassisted mediastinoscopic lymphadenectomy (VAMLA) in selected cases [9, 10] . The surgical margin was defined as the smallest distance between the tumour and the parenchymal resection margin, and was determined at gross pathological examination of the deflated lung segment. Distances in the range of 1 cm or below were measured exactely at microscopic examination. Before embedding the tissue, the 1 mm wide stapling line was routinely cutoff. The data were not corrected for the resulting systematic underestimation of the resection margin of 1 mm. The perioperative course was assessed by 30-day mortality, morbidity, chest tube drainage time, hospital stay, transfusions and blood loss. 
Institutional Report
All but six of 39 intraoperative unexpected findings or adverse events were mastered by thoracoscopical means (Table 3) . Seven patients received one and 13 patients two chest tubes. The postoperative course was uneventful in 15 patients. There were no readmissions and a zero 30-day mortality. In five patients, we observed 10 postoperative adverse events, five of them medical (atrial fibrillation, cardiac decompensation, pneumonia, and two respiratory insuffi ciency) and five surgical (two prolonged air leaks, two residual pleural space and one temporary left recurrent nerve paralysis). No transfusions were required. Comparison of the haemoglobin concentrations on the preoperative and the seventh postoperative day showed a median decrease of 0.75 (range 0-2.73) mmol/l. The last chest tube was removed after a median of six (range 3-21) days. The median postoperative hospital stay was 8.5 (range 5-25) days.
Definitive pathological examination of the specimen showed 17 lung carcinomas (nine squamous cell and eight adenocarcinoma), one low-grade and one benign mesenchymal tumour, and one metastasis of an extrathoracic malignancy. The distance between the tumour and the parenchymal stapling line was more than 2 cm in 45%, 20% and 17% of T1a, T1b and T2 tumours, respectively, and exceeded the tumour diameter in 56%, 0% and 0% of cases, respectively (Fig. 4) . After pTNM restaging, 7/20 clinically stage I patients had to be upstaged (Table 4) . Four of them received adjuvant radiation, and three received adjuvant chemotherapy.
Discussion
From a technical point of view, cVATS segmentectomy is in many aspects a small-scale cVATS lobectomy. It can be performed safely using the very same instruments and staplers commercially available for thoracoscopic surgery, shows similar intra-and postoperative adverse events, and leads to comparable clinical results [11] . Standard VATS lobectomy approaches are applicable. For the dorsally located segments 2 and 6, we suggest starting the dissection posteriorly and proceeding in an anterior direction [12] . All other segments and the segment groups can be dissected in anterior-posterior direction [8] . We felt no need to adapt our incisions to different segments or strategies. The comparatively long postoperative stay of median 8.5 days has several underlying reasons. First, it is related to the median six days of chest tube drainage that is best explained by the presence of chronic obstructive pulmonary disease (COPD) with emphysema in nine patients, a fused fissure in six, and a fused pleural space in six patients, resulting in prolonged air leaks of seven or more days in two patients, as well as by the thorougly performed dissection of the lobar and segmental structures. We also noted relevant non-surgical comorbidities needing special attention during the postoperative care of five patients, and a high proportion of elderly patients. Finally, most patients in our country are unwilling to leave hospital with residual complaints or indwelling drains.
With cVATS segmentectomy, we experienced three main challenges: the lymphadenectomy, the resection margin and identification of the intersegmental plane. Oncological segmentectomies require tumour-free peribronchial lymph nodes, otherwise a conversion to lobectomy is indicated, as in three of our 20 cases. Thus, peribronchial lymph node dissection not only at the lobar, but also at the segmental level needs the greatest care and at the very least frozen sections of suspicious nodes. Additional complete medias- tinal dissection is advisable, as mediastinal nodes are involved in about 15% of T1 tumours [13] . For the same reason, we recommend a combined VATS+VAMLA approach [7] to left-sided tumours to make a pre-and paratracheal dissection possible and to facilitate complete dissection of the subcarinal space.
The surgical margin at the parenchyma of the intersegmental plane is worth some consideration with regard to its thoracoscopic definition, the division and its pathologi cal assessment. A margin of 1 cm [2] is achievable in most cases regardless of the tumour diameter. However, the resection margin is unlikely to exceed the tumour diameter if the tumour diameter is above 2 cm, reflected by a margin to-diameter ratio of one achievable only for T1 tumours. Sharp and blunt dissection of the intersegmental plane during differential or jet ventilation cannot be fully adopted from open surgery or hybrid VATS [14] for reasons of impaired visibility and access. If emphysema is present, the pores of Kohn are well developed and make the intersegmental borders even harder to define. In this situation, further thoracoscopic dissection of the segmental vein will indicate the direction in which to place the stapler. Thus, VATS division of the intersegmental parenchyma by stapler is feasible and prevents air leaks, but it is probably inferior with regard to maintaining accurate anatomical segmental borders. Furthermore, the stapled parenchymal margin is a point of inaccuracy in the pathological assessment of its distance to the tumour, especially if assessed microscopically or with the specimen perfused. The measurable impact of this theoretical disadvantage of stapling in terms of local recurrence or survival has never been investigated.
Despite these unanswered questions, VATS segmentectomy is an appealing concept in terms of providing a parenchymasparing as well as minimally-invasive cancer operation. It is a feasible procedure from the surgical, clinical and oncological point of view as it provides reasonable resection margins for T1a tumours, complete lymph node dissection, and an acceptable postoperative course in a high-risk population. However, it is the recurrence-free and longterm survival of early-stage lung carcinoma patients treated by VATS segmentectomy that will show whether it is an adequate cancer operation for T1a lung carcinoma regardless of lung function. Long-term results should be at least equal to those of VATS lobectomy as well as open segmentectomy, and superior to radiation therapy and radiofrequency ablation. At present, it is not possible to provide convincing long-term results. However, a series of more than 80 VATS segmentectomies collected by Swanson [5] suggesting a favourable postoperative course and adequate survival data should encourage further clinical investigation.
